Pre-clinical evaluation of [111In-DTPA-Pro1, Tyr4]bombesin, a new radioligand for bombesin-receptor scintigraphy

International Journal of Cancer

Volumn 83, Issue 5, 1999, Pages 657-663

  Breeman, Wout A P ^a   De Jong, Marion ^a   Bernard, Bert F ^a   Kwekkeboom, Dik J ^a   Srinivasan, Ananth ^b   Van Der Pluijm, Marcel E ^a   Hofland, Leo J ^a   Visser, Theo J ^a   Krenning, Eric P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; BOMBESIN RECEPTOR; INDIUM; PENTETATE INDIUM IN 111; PROLACTIN; PROLINE; RADIOLIGAND; TYROSINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SCREENING; DRUG UPTAKE; DRUG URINE LEVEL; HORMONE RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SCINTIGRAPHY;

ANIMALS; BOMBESIN; DRUG EVALUATION, PRECLINICAL; INDIUM RADIOISOTOPES; MALE; PENTETIC ACID; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW; RECEPTORS, BOMBESIN; TISSUE DISTRIBUTION;

EID: 0032706253     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991126)83:5<657::AID-IJC15>3.0.CO;2-Y     Document Type: Article

References (29)

1. APRIKIAN, A.G., TREMBLAY, L., HAN, K. and CHEVALIER, S., Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. Int. J. Cancer, 72, 498-504 (1997).
2. 1]octreotide, a potential radiopharmaceutical for imaging of somatostatin-receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci., 49, 1583-1591 (1991a).
3. 1]octreotide for detection of somatostatin-receptor-positive tumors in rats. Life Sci., 49, 1593-1601 (1991b).
4. BOSTWICK, D.G. and BENSCH, K.G., Gastrin-releasing peptide in human neuro-endocrine tumors. J. Pathol., 147, 237-244 (1985).
5. 3 derivatives of octreotide in rats. Anticancer Res., 18, 83-90 (1998).
6. 3]octreotide. Europ. J. nucl. Med, 20, 1089-1094 (1993).
7. BREEMAN, W.A.P., HOFLAND, L.J., DE JONG, M., BERNARD, B., SRINIVASAN, A., VAN DER PLUIJM, M.E., VISSER, T.J. and KRENNING, E.P., Evaluation of radiolabeled bombesin analogs for receptor-targeted scintigraphy and radiotherapy. Int. J. Cancer, 81, 658-665 (1999).
8. 1]octreotide. Europ. J. nucl. Med., 21, 328-335 (1994).
9. BREEMAN, W.A.P., KWEKKEBOOM, D.J., KOOIJ, P.P.M., BAKKER, W.H., HOFLAND, L.J., VISSER, T.J., ENSING, G.J., LAMBERTS, S.W.J. and KRENNING, E.P., Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J. nucl. Med., 36, 623-627 (1995).
10. 1]substance P. J. nucl. Med., 37, 108-117 (1996).
11. COY, D.H., WANG, L.H., JIANG, N.Y. and JENSEN, R.T., Short-chain pseudopeptides with potent bombesin-receptor-antagonist activity in rat and guinea pig pancreatic acinair cells. Europ. J. Pharmacol., 190, 31-38 (1990).
12. CUTTITA, F., CARNEY, D.N., MULSHINE, J., MOODY, T.W., FREDORKO, J., FISCHLER, A. and MINNA, J.D., Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (Lond.), 316, 823-826 (1985).
13. DAVIS, T.P., CROWELL, S., TAYLOR, J., CLARK, D.L., COY, D., STALEY, J. and MOODY, T.W., Metabolic stability and tumor inhibition of bombesin/GRP-receptor antagonist. Peptides, 13, 401-407 (1992).
14. 111In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res., 58, 437-441 (1998).
15. DEMICHELE, M.A.A., GAITHER DAVIS, A.L., HUNT, J.D., LANDRENEAU, J. and SIEGFRIED, J.M., Expression of mRNA for three bombesin receptor sub-types in human bronchial epithelial cells. Amer. J. respir. cell. mol. Biol., 11, 66-74 (1994).
16. DUNCAN, J.R., STEPHENSON, M.T., WU, H.P. and ANDERSON, C.J., Indium-111-diethyletriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor-cell, renal and hepatocyte lysosomes. Cancer Res., 57, 659-671 (1997).
17. HAJRI, A., KOENIG, M., BALBONI, G. and DAMGE, C., Expression and characterization of gastrin-releasing peptide receptor in normal and cancerous pancreas. Pancreas, 12, 25-35 (1996).
18. JANSEN, J.B.M.J., JEBBINK, M.C.W., DOUGLAS, B.R. and LAMERS, C.B.H.W., Effect of loxiglumide (CR1505) on bombesin-and meal-stimulated plasma-cholecystokinin release in man. Europ. J. clin. Pharmacol., 28, 367-370 (1990).
19. JENSEN, R.T. and COY, D.H., Progress in the development of potent bombesin-receptorantagonists. TIPS, 12, 13-19 (1991).
20. KRENNING, E.P., BAKKER, W.H., BREEMAN, W.A.P., KOPER, J.W., KOOIJ, P.P.M., AUSEMA, L., LAMERIS, J.S. and LAMBERTS, S.W.J., Localization of endocrine-related tumours with radio-iodinated analogue of somatostatin. Lancet, 1, 242-245 (1989).
21. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Europ. J. nucl. Med., 20, 716-731 (1993).
22. PRESTON, S.R., WOODHOUSE, L.F., JONES-BLACKETT, S., WYATT, J.L. and PRIMROSE, J.N., High-affinity binding sites for gastrin-releasing peptide on human gastric cancer and Ménétrier's mucosa. Cancer Res., 53, 5090-5092 (1993).
23. QIN, Y., HALMOS, G., CAI, R-Z., SZOKE, B., ERTL, T. and SCHALLY, A.V., Bombesin antagonist inhibits in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors. J. Cancer. Res. clin. Oncol., 120, 519-528 (1994).
24. 2 in ovarian carcinoma induced to express the gastrin-releasing peptide receptor by adenoviral-vector-mediated gene transfer. J. nucl. Med., 38, 1221-1229 (1997).
25. SNEDECOR, G.W. and COCHRAN, W.G., Statistical methods (7th ed.), pp. 233-236, Iowa State University Press, Ames (1980).
26. VAN EUCK, C.H.J., SLOOTER, G.D., HOFLAND, L.J., KORT, W., JEEKEL, J., LAMBERTS, S.W.J. and MARQUET, R.L., Somatostatin-receptor-dependent growth inhibition of liver metastases by octreotide. Brit. J. Surg., 81, 1333-1337 (1994).
27. VAN HAGEN, M.P., BREEMAN, W.A.P., REUBI, J.C., POSTEMA, P.T.E., VAN DEN ANKER-LUGTENBURG, E.J., KWEKKEBOOM, D.J., LAISSUE, J., WASER, B., LAMBERTS, S.W.J., VISSER, T.J. and KRENNING, E.P., Visualization of the thymus by substance-P scintigraphy in man. Europ. J. Nucl. Med., 23, 1508-1513 (1996).
28. WANG, L.H., COY, D.H., TAYLOR, J.E., JIANG, N.Y., KIM, S.H., MOREAU, J-P., HUANG, S.H., MANTEY, S.A., FRUCHT, H. and JENSEN, R.T., Desmethionine alkylamide bombesin analogue: a new class of bombesin-receptor antagonist with potent anti-secretory activity in pancreatic acini and anti-mitotic activity in Swiss 3T3 cells. Biochemistry, 29, 616-622 (1990).
29. WANG, L.H., MANTEY, J.T., FRUCHT, L.H. and JENSEN, R.T., Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin-receptor sub-types: a comparative study. Biochem. biophys. Acta, 1175, 232-242 (1993).